Document is current
Any future updates will be listed below
-
Authors
Batatinha, Helena
Niemiro, Grace M.
Peña, Nicole A.
Hoskin, Giovannah A.
Zúñiga, Tiffany M.
Smith, Kyle A.
Baker, Forrest L.
Diak, Douglass M.
Mylabathula, Preteesh L.
Kistner, Timothy M.
Seckeler, Michael D.
Katsanis, Emmanuel
Simpson, Richard J.
-
Funding
Funding for this research was provided by:
NIH Clinical Center (R01CA277493-01)
- License Information
-
More Information
Article History
Received: 5 May 2025
Accepted: 3 October 2025
First Online: 5 November 2025
Declarations
:
: The experiments with humans were approved by the Human Subjects Protection Program at the University of Arizona #1711017841 “Isoproterenol Infusion and Donor Stem Cell Graft Composition” on 10/24/2017. Written informed consent and medical history were obtained from each participant after a proper explanation of the procedures and risks. The experiments with mice were approved by the University of Arizona Institutional Animal Care and Use Committee (IACUC) under protocol number 17–338 “Human PBMC xenotransplantation into mice with cancer” on 06/01/2018.
: Not applicable.
: There are no conflicts of interest.
